drugset / Trial / NCT07230483
A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an Open-label ,Multicenter Study to evaluate Long-Term Safety and Efficacy of CM512 in patients with Atopic Dermatitis who have completed treatment in parent CM512 Study.
Timeline
- Start
- 2025-12
- Primary completion
- 2027-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM512 | Unknown | — | Subcutaneous |